Fig. 4
From: SLC26A4 correlates with homologous recombination deficiency and patient prognosis in prostate cancer
Clinicopathological features in HRD clusters. The differences in A patient age, B Gleason score, C primary outcome, D biochemical recurrence, E pathologic T stage, and F N stage in three HRD clusters. The differential PARADIGM pathways G between clusters 1 and 2, and H between clusters 1 and 3. I The differences in biological pathways at the protein level in HRD clusters. The statistical significance is indicated as asterisks (*), *p < 0.05, ** p < 0.01, ***p < 0.001, ns: not significant